Back to AG Adage Capital Partners GP, L.L.C.

ACRSACRS

Showing 7 of 26 quarters

Position history for AGAdage Capital Partners GP, L.L.C.'s holdings in Aclaris Therapeutics, Inc.

Yes. Adage Capital Partners GP holds 4,071,000 shares of ACRS (Aclaris Therapeutics), worth $21.5M, as of its Q2 2026 13F filing. It increased the position by 200,000 shares (+5.2%) from Q1 2026. Adage Capital Partners GP has held ACRS since Q4 2024, across 7 quarterly 13F filings.

Current Value

$21.5M

Current Shares

4.1M

Total Value Change

-$2.3M

Total Shares Change

-5.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
4.1M
+5.2%
$21.5M0.0%$5.29
30
2026-Q1
Increased
3.9M
+14.8%
$14.5M0.0%$3.75
32
2025-Q4
Decreased
3.4M
-36.1%
$10.1M0.0%$3.01
0
2025-Q3
Decreased
5.3M
-45.2%
$10M0.0%$1.90
0
2025-Q2
Unchanged
9.6M
0.0%
$13.7M0.0%$1.42
0
2025-Q1
Unchanged
9.6M
0.0%
$14.7M0.0%$1.53
0
2024-Q4
New
9.6M
—
$23.9M0.0%$2.48
40

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used